Sanovas launches SinuGeniX sinus treatment subsidiary

Sanovas recently announced the launch of SinuGeniX, a wholly-owned subsidiary focused on treating chronic sinusitis with the company’s RegENT sinus treatment system. The newly-launched subsidiary won’t just supply a single tool for treating chronic sinusitis, which affects over 28 million Americans, but a suite of technologies, Sanovas CEO and system co-inventer Larry Gerrans told MassDevice.com in an interview. “I wanted to create the tool belt, not just the tool. We’ve created a number of very complimentary tools that will improve physicians access and imaging along with the treatment procedure and measurement. It runs with the theme which I’ve always had, which is that you have to AIM – access, image and measure. Then you have the ability to perform diagnostics and treatment,” Gerrans said. The company looks to deliver a suite of technologies to handle the procedure, Gerrans said. Included in the RegENT system are a deflectable needle for improved anesthetization, advanced procedural visualization through a smart, semi-compliant balloon catheter designed for maintaining healthy anatomy, and navigation with an articulated guide-sheath. “Peer reviewed data suggests that more than 20% of the 13 million U.S. patients that are treated with medication for chronic sinusitis fail to respond.  So, there are about 2.6 million patients looking to surgery as an ultimate solution. However, current treatments in sinus surgery aren’t preci...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Catheters Otolaryngology Ear, Nose & Throat Sanovas Source Type: news